moxisylyte has been researched along with alprostadil in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Porst, H | 1 |
| Bondil, P | 1 |
| Buvat, J; Herbaut-Buvat, M; Lemaire, A | 1 |
| Albrecht, D; Buvat, J; Costa, P; Lecocq, B; Morlier, D; Stegmann, B | 1 |
| Gingell, JC | 1 |
| Boiteau, F; Boyer, F; Dizien, O; Laffont, I; Lebib Ben Achour, S | 1 |
| Bonan, I; Chéhensse, C; Chochina, L; Damphousse, M; Giuliano, F; Manunta, A; Naudet, F | 1 |
2 review(s) available for moxisylyte and alprostadil
| Article | Year |
|---|---|
New developments in self-injection therapy for erectile dysfunction.
Topics: Alprostadil; Calcitonin Gene-Related Peptide; Chlorpromazine; Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Injections; Male; Moxisylyte; Papaverine; Patient Satisfaction; Phentolamine; Self Administration; Sympatholytics; Treatment Outcome; Vasoactive Intestinal Peptide; Vasodilator Agents | 1998 |
Intracavernous Injections in Spinal Cord Injured Men With Erectile Dysfunction, a Systematic Review and Meta-Analysis.
Topics: Alprostadil; Erectile Dysfunction; Humans; Male; Moxisylyte; Papaverine; Penile Erection; Prospective Studies; Retrospective Studies; Spinal Cord Injuries; Vasodilator Agents | 2016 |
2 trial(s) available for moxisylyte and alprostadil
| Article | Year |
|---|---|
Double-blind multicenter study comparing alprostadil alpha-cyclodextrin with moxisylyte chlorhydrate in patients with chronic erectile dysfunction.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; alpha-Cyclodextrins; Alprostadil; Chronic Disease; Cyclodextrins; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Moxisylyte; Vasodilator Agents | 1998 |
[Intracavernous injections in the treatment of erectile dysfunction in spinal cord injured patients: experience with 36 patients].
Topics: Adult; Alprostadil; Erectile Dysfunction; Humans; Male; Moxisylyte; Papaverine; Patient Satisfaction; Spinal Cord Injuries; Vasodilator Agents | 2001 |
4 other study(ies) available for moxisylyte and alprostadil
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
The rationale for prostaglandin E1 (alpha-alprostadil) in the management of male impotence.
Topics: Alprostadil; Erectile Dysfunction; Humans; Impotence, Vasculogenic; Male; Molsidomine; Moxisylyte; Papaverine; Penile Induration; Phentolamine | 1995 |
[Treatment of erectile insufficiency].
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Alprostadil; Erectile Dysfunction; Humans; Male; Moxisylyte; Psychotropic Drugs; Sex Education | 1995 |
Intracavernous pharmacotherapy: comparison of Moxisylyte and prostaglandin E1.
Topics: Adult; Aged; Alprostadil; Dose-Response Relationship, Drug; Erectile Dysfunction; Fibrosis; Humans; Impotence, Vasculogenic; Injections; Male; Middle Aged; Moxisylyte; Penis; Priapism; Retrospective Studies; Vasodilator Agents | 1996 |